| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 1,720.35 | 1,947.92 | 1,154.22 | 223.76 |
| Accumulated Depreciation Total | -0.21 | -0.18 | - | - |
| Other Liabilities Total | 0.00 | - | - | - |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Total | 40.32 | 10.08 | 3.60 | 3.60 |
| Other Current Assets Total | 2.11 | 2.09 | 0.58 | 0.16 |
| Total Assets | 1,720.35 | 1,947.92 | 1,154.22 | 223.76 |
| Cash | 1.43 | 1.52 | 21.61 | 0.74 |
| Total Equity | 43.89 | 42.96 | 10.36 | 4.94 |
| Retained Earnings( Accumulated Deficit) | 3.57 | 32.88 | 6.76 | 1.34 |
| Total Common Shares Outstanding | 57.77 | 57.77 | 57.77 | 57.77 |
| Property/ Plant/ Equipment Total- Gross | 0.22 | 0.22 | - | - |
| Tangible Book Valueper Share Common Eq | 0.76 | 0.74 | 0.18 | 0.08 |
| Total Liabilities | 1,676.46 | 1,904.97 | 1,143.86 | 218.82 |
| Total Debt | 1,141.39 | 57.70 | 0.00 | 0.00 |
| Short Term Investments | 0.39 | 0.03 | - | - |
| Cashand Short Term Investments | 1.82 | 1.55 | 21.86 | 1.44 |
| Total Receivables Net | 778.00 | 925.50 | 1,124.38 | 138.11 |
| Notes Payable/ Short Term Debt | 1,141.39 | 57.70 | 0.00 | 0.00 |
| Accounts Receivable- Trade Net | 771.62 | 920.60 | 172.37 | 64.00 |
| Property/ Plant/ Equipment Total- Net | 0.01 | 0.05 | 0.08 | 0.09 |
| Total Current Liabilities | 1,676.46 | 1,904.97 | 1,143.86 | 218.82 |
| Total Inventory | 938.37 | 1,018.72 | 7.32 | 83.87 |
| Accounts Payable | 500.96 | 712.29 | 84.22 | 124.56 |
| Other Currentliabilities Total | 34.10 | 1,134.98 | 1,059.64 | 94.26 |
| Total Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Long Term Assets Total | 0.04 | 0.03 | 0.01 | 0.00 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 1,720.30 | 1,947.85 | 1,154.14 | 223.57 |
| Long Term Investments | - | 0.00 | - | - |
| Deferred Income Tax | - | 0.00 | 0.00 | 0.00 |
| Intangibles Net | - | 0.00 | - | 0.10 |
| Cash Equivalents | - | - | 0.24 | 0.70 |
Supha Pharmachem Ltd Dividend Supha Pharmachem Ltd Bonus Supha Pharmachem Ltd News Supha Pharmachem Ltd AGM Supha Pharmachem Ltd Rights Supha Pharmachem Ltd Splits Supha Pharmachem Ltd Board Meetings Supha Pharmachem Ltd Key Metrics Supha Pharmachem Ltd Shareholdings Supha Pharmachem Ltd Profit Loss Supha Pharmachem Ltd Cashflow Supha Pharmachem Ltd Q1 Results Supha Pharmachem Ltd Q2 Results Supha Pharmachem Ltd Q3 Results Supha Pharmachem Ltd Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks